erythromycin ethylsuccinate has been researched along with Bile Duct Obstruction, Intrahepatic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boitnott, JK; Diehl, AM; Latham, P; Maddrey, WC; Mann, J | 1 |
| Bachman, BA; Boyd, WP; Brady, PG | 1 |
| Aglas, F; Horina, JH; Horn, S | 1 |
| Dive, C; Geubel, AP; Nakad, A; Rahier, J | 1 |
4 other study(ies) available for erythromycin ethylsuccinate and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases.
Topics: Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Hyperbilirubinemia; Jaundice; Liver; Middle Aged; Transaminases | 1984 |
Erythromycin ethylsuccinate-induced cholestasis.
Topics: Abdomen; Cholestasis, Intrahepatic; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Liver; Liver Function Tests; Middle Aged; Pain | 1982 |
Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate.
Topics: Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Drug Hypersensitivity; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Recurrence; Retreatment; Structure-Activity Relationship | 1999 |
Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?
Topics: Bile Ducts, Intrahepatic; Chemical and Drug Induced Liver Injury; Chlorpropamide; Cholestasis, Intrahepatic; Diabetes Mellitus, Type 2; Drug Interactions; Erythromycin; Erythromycin Ethylsuccinate; Humans; Male; Middle Aged; Time Factors | 1988 |